Announcements
- Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter
- Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility
- Scorpius Holdings Announces Reverse Stock Split
- Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
- Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing
- Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
- Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility
- Scorpius Holdings, Inc. Announces Closing of Public Offering
- Scorpius Holdings Commends Congress on Bipartisan Legislative Action Aimed at Bolstering U.S. Biomanufacturing
- Scorpius Holdings Achieves Major Milestone with cGMP Facility Validation for Microbial Manufacturing
More ▼
Key statistics
On Friday, Scorpius Holdings Inc (1HB0:FRA) closed at 10.00, 0.00% above its 52-week low of 10.00, set on Jun 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 10.00 |
Low | 10.00 |
Bid | -- |
Offer | -- |
Previous close | 10.00 |
Average volume | -- |
---|---|
Shares outstanding | 494.14k |
Free float | 474.95k |
P/E (TTM) | -- |
Market cap | 1.04m USD |
EPS (TTM) | -244.34 USD |
Data delayed at least 15 minutes, as of Jun 14 2024 07:09 BST.
More ▼